We serve Chemical Name:(2R)-2-amino-2-(4-fluorophenyl)acetic acid,hydrochloride CAS:144744-41-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2R)-2-amino-2-(4-fluorophenyl)acetic acid,hydrochloride
CAS.NO:144744-41-2
Synonyms:(R)-2-Amino-2-(4-fluorophenyl)acetic acid hydrochloride;(R)-AMINO-(4-FLUORO-PHENYL)-ACETIC ACID HYDROCHLORIDE;(R)-(p-Fluorophenyl)glycine hydrochloride;(R)-4-FLUOROPHENYLGLYCINE-HCl;D-4-FLUOROPHENYLGLYCINE HCL
Molecular Formula:C8H9ClFNO2
Molecular Weight:205.61400
HS Code:2922499990
Physical and Chemical Properties:
Melting point:N/A
Boiling point:321.2ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:63.32000
Exact Mass:205.03100
LogP:2.41240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (R)-2-Amino-2-(4-fluorophenyl)acetic acid hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-4-FLUOROPHENYLGLYCINE HCL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-(p-Fluorophenyl)glycine hydrochloride Use and application,(R)-(p-Fluorophenyl)glycine hydrochloride technical grade,usp/ep/jp grade.
Related News: There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% 6-(4-chloro-3-methyl-phenyl)-2-(2-hydroxy-butyl)-4,5-dihydro-2H-pyridazin-3-one manufacturers Symonds’ board has backed Walmsley’s leadership. In response to Elliott’s open attack earlier this month, the GSK board said it “strongly believes” Walmsley is the “right leader” for the company, citing “widespread and strong support” from GSK’s largest shareholders for Walmsley’s newly unveiled plan to improve the company’s performance. 3-Thiophenecarboxamide, tetrahydro-2,4-dioxo-N,5-diphenyl- suppliers AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. 5-(azepan-1-ylsulfonyl)-N-(2-methoxybenzyl)-3-methylbenzofuran-2-carboxamide vendor & factory.
